Serum CA 19-9 and CA 50 antigens in hemodialysis patients.
Copyright policy )Serum CA 19-9 and CA 50 antigens in hemodialysis patients.
Serum concentrations of monoclonal antibody-defined tumor markers CA 19-9 and CA 50 were measured in 64 uncomplicated hemodialysis patients (Group 1) and in 8 hemodialysis patients with cancer (Group 2) in comparison with corresponding CEA determinations. From our results in Group 1 patients it appears that both CA 19-9 and CA 50 maintained an excellent specificity in these patients. As to the sensitivity of these tests, our findings in Group 2 patients are comparable with those reported in patients with cancer and normal renal function. It is concluded that, unlike CEA, these new tumor markers maintain their clinical value in chronic renal failure.
Adult, Male, Middle Aged, Carcinoembryonic Antigen, Antigens, Neoplasm, Renal Dialysis, Humans, Antigens, Tumor-Associated, Carbohydrate, Female, Diagnostic Errors, Aged, Gastrointestinal Neoplasms, Uremia
Adult, Male, Middle Aged, Carcinoembryonic Antigen, Antigens, Neoplasm, Renal Dialysis, Humans, Antigens, Tumor-Associated, Carbohydrate, Female, Diagnostic Errors, Aged, Gastrointestinal Neoplasms, Uremia
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).15 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Average influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Top 10% impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Average
Citations provided by BIP!Popularity provided by BIP!